To pioneer transformative minimally invasive ophthalmic fluid delivery devices that safely help preserve and restore vision and improve the quality of life for patients, beginning with the treatment of retinal detachment and expanding to a broader range of ophthalmic disorders.
To be the global leader in pioneering treatment options for various ocular disorders by advancing innovative interventions that improve access to suprachoroidal and subretinal locations.
